Enrolling by invitationNCT07264166
Intranasal AAV9-PHP.eB Gene Therapy in Cerebral Palsy (CP) & Hypoxic Ischemic Encephalopathy (HIE)
Studying Neonatal hypoxic and ischemic brain injury
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Healing Hope International
- Principal Investigator
- Dr. Anna Lara Kattan, MD: Regenerative MedicineStem Solutions
- Enrollment
- 25 target
- Eligibility
- 2-65 years · All sexes
- Timeline
- 2026 – 2032
Study locations (1)
- Stem Solutions, Monterrey, Nuevo León, Mexico
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07264166 on ClinicalTrials.govOther trials for Neonatal hypoxic and ischemic brain injury
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07464938New Tools and Predictive Markers in the Prognosis of Hypoxic-ischemic Encephalopathy Following Cardiac ArrestCliniques universitaires Saint-Luc- Université Catholique de Louvain
- ENROLLING BY INVITATIONPHASE1NCT06429007A Safety and Feasibility Trial Protocol of Metformin in Infants After Perinatal Brain InjuryBoston Children's Hospital
- RECRUITINGNANCT06762795The HIEnome Study: Genome Sequencing for Perinatal HIEBaylor College of Medicine
- RECRUITINGNCT07136636Speech of Kids After Neonatal EncephalopathySemmelweis University
- RECRUITINGEARLY PHASE1NCT06746532Intranasal Breast Milk Therapy in HIESemmelweis University
- RECRUITINGEARLY PHASE1NCT06747260Feasibility and Safety of Intranasally Administered Breast Milk in HIESemmelweis University
- RECRUITINGNANCT06563687Continuous Glucose Monitoring in HIEUniversity of Campania Luigi Vanvitelli
- RECRUITINGPHASE1NCT06448780Dose Optimization of Caffeine for HIEUniversity of North Carolina, Chapel Hill
See all trials for Neonatal hypoxic and ischemic brain injury →